We previously reported local administration of a pharmacological dose of granulocyte-macrophage colony-stimulating factor (GM-CSF) induces mononuclear phagocytes to overexpress soluble VEGF receptor-1 (sVEGFR-1) and decrease vessel density in murine breast tumors [92]. The gene discussed is CSF2; the disease is breast neoplasm.